Related Experiment Video
Updated: Jun 25, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Rapid Progression of Malignant Peritoneal Mesothelioma Mimicking a Postoperative Complication in a Young Woman: A
Paulina Christine Altshuler1, Anna Le Newman1, Jorge A Garibay1
1Department of Obstetrics and Gynaecology, Intermountain Healthcare, Saint Joseph Hospital, Denver, CO, USA.
Abstract:
BACKGROUND Malignant peritoneal mesothelioma is a rare disease with a poor prognosis that often presents with vague symptoms and inconclusive laboratory test results. Causes include industrial pollutants, primarily asbestos, and certain genetic mutations, such as BAP1. Due to the nonspecific symptoms, it is often incidentally diagnosed during or after other surgical procedures. CASE REPORT A 35-year-old healthy woman underwent an uncomplicated laparoscopic left salpingo-oophorectomy for a symptomatic large ovarian mature cystic teratoma. She subsequently presented with late-onset postoperative fever, leukocytosis, and multiple intra-abdominal masses. Following an exploratory laparotomy, extensive infectious disease evaluation, and multiple biopsies requiring interdisciplinary collaboration, malignant peritoneal mesothelioma was diagnosed by positive histologic staining of an omental biopsy for D2-40 and CK5/6. This first specimen was positive for BAP1, with the second, a liver biopsy, testing negative for BAP1. The tumor cell testing was also notable for mutations in NF2, MLL2, and ARID1A, and the hereditary cancer genetic testing was overall unremarkable. Her disease progressed rapidly, and she died 6 months after her initial procedure. CONCLUSIONS This case of rapidly developing malignant peritoneal mesothelioma following surgical management of an ovarian mature teratoma highlights the complexity in diagnosing a rare disease that presents with nonspecific symptoms in an otherwise young and healthy woman. The rapid disease course was likely accelerated by expansive intraperitoneal spread and multiple somatic oncogenic mutations in BAP1, NF2, MLL2, and ARID1A. Gynecologists should keep a broad differential for postoperative complications, as occult malignancies can present with symptoms that mimic postoperative complications.
Insights
Malignant peritoneal mesothelioma is a rare cancer. This case shows a young woman’s rapid progression after ovarian surgery, emphasizing the need for broad differentials in postoperative complications.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Malignant peritoneal mesothelioma is a rare cancer with poor prognosis.
- Causes include asbestos exposure and genetic mutations like BAP1.
- Nonspecific symptoms often lead to incidental diagnosis during surgery.
Observation:
- A 35-year-old woman developed postoperative fever, leukocytosis, and intra-abdominal masses after ovarian teratoma surgery.
- Biopsies revealed malignant peritoneal mesothelioma with specific genetic mutations.
- The patient experienced rapid disease progression and mortality within 6 months.
Findings:
- Histologic staining confirmed mesothelioma with D2-40 and CK5/6 positivity.
- Tumor cells showed mutations in BAP1, NF2, MLL2, and ARID1A.
- Rapidly progressing mesothelioma can occur in young, healthy individuals.
Implications:
- This case underscores the diagnostic challenges of rare peritoneal mesothelioma.
- Gynecologists must consider occult malignancies in postoperative complications.
- Genetic mutations may drive rapid mesothelioma progression.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:

